Lipocine Inc (LPCN)
6.05
+0.30
(+5.22%)
USD |
NASDAQ |
May 17, 16:00
6.20
+0.15
(+2.48%)
After-Hours: 20:00
Lipocine Price to Book Value: 1.348 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.348 |
| May 16, 2024 | 1.284 |
| May 15, 2024 | 1.255 |
| May 14, 2024 | 1.194 |
| May 13, 2024 | 1.179 |
| May 10, 2024 | 1.188 |
| May 09, 2024 | 1.170 |
| May 08, 2024 | 1.083 |
| May 07, 2024 | 1.118 |
| May 06, 2024 | 1.098 |
| May 03, 2024 | 1.045 |
| May 02, 2024 | 1.049 |
| May 01, 2024 | 1.051 |
| April 30, 2024 | 1.031 |
| April 29, 2024 | 1.056 |
| April 26, 2024 | 1.071 |
| April 25, 2024 | 1.016 |
| April 24, 2024 | 0.9912 |
| April 23, 2024 | 1.072 |
| April 22, 2024 | 1.132 |
| April 19, 2024 | 1.176 |
| April 18, 2024 | 1.214 |
| April 17, 2024 | 1.188 |
| April 16, 2024 | 1.063 |
| April 15, 2024 | 1.195 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.289 |
| April 11, 2024 | 1.422 |
| April 10, 2024 | 1.444 |
| April 09, 2024 | 1.280 |
| April 08, 2024 | 1.167 |
| April 05, 2024 | 1.065 |
| April 04, 2024 | 1.023 |
| April 03, 2024 | 1.094 |
| April 02, 2024 | 1.103 |
| April 01, 2024 | 1.176 |
| March 31, 2024 | |
| March 28, 2024 | 1.357 |
| March 27, 2024 | 1.338 |
| March 26, 2024 | 1.308 |
| March 25, 2024 | 1.148 |
| March 22, 2024 | 1.054 |
| March 21, 2024 | 1.073 |
| March 20, 2024 | 1.104 |
| March 19, 2024 | 1.112 |
| March 18, 2024 | 1.172 |
| March 15, 2024 | 1.200 |
| March 14, 2024 | 1.224 |
| March 13, 2024 | 1.25 |
| March 12, 2024 | 1.033 |
| March 11, 2024 | 0.9421 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5269
Minimum
Sep 28 2023
12.07
Maximum
Feb 10 2021
3.267
Average
2.635
Median
Jan 14 2020
Price to Book Value Benchmarks
| Alpine Immune Sciences Inc | 13.40 |
| Eliem Therapeutics Inc | 2.256 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
Price to Book Value Related Metrics
| Price | 6.05 |
| Earnings Yield | -28.31% |
| Market Cap | 32.30M |